Font Size: a A A
Keyword [decitabine]
Result: 181 - 200 | Page: 10 of 10
181. Experimental Study On The Expression Of Reprimo Gene In Human Gastric Cancer Cell Line SNU-1 By Dexitabine Combined With Apatinib
182. Study On The Clinical Application And Mechanism Of Decitabine And Ruxolitinib In Myeloproliferative Neoplasm And Acute Graft-versus-host Diseace
183. Analysis Of Clinical Efficacy And Influencing Factors Of Decitabine Alone Or In Combined With Pre-excitation Regimen In Treatment For Patients With Myelodysplastic Syndrome With Excess Blasts
184. The Effect And Mechanism Of Decitabine In Combination With Adoptive γδ T Cell Therapy Against Osteosarcoma
185. The Study On ID1 Involved In Decitabine Resistance In Acute Myeloid Leukemia
186. Comparison Of Clinical Efficiency Of Decitabine Combined With Low-intensity Chemotherapy Regimen And Standard Chemotherapy Regimen In Elderly Patients With Acute Myeloid Leukemia
187. Analysis Of The Efficacy And Safety Of Sequential Decitabine Combined With Priming Regimen For Newly Diagnosed Acute Myeloid Leukemia Induced By Standard Protocol Without Myelosuppression
188. Study On The RhTPO Promotes Patelet Recovery Of DCAG Treated Intermediate And High Risk MDS/Low-Proliferation AML
189. The Analysis Of Demethylation Treatment And The Application Of Comprehensive Geriatric Assessment In Myelodysplastic Syndrome
190. Clinical Study Of Yisuifang Combined With EPO/low-dose Decitabine In The Treatment Of Myelodysplastic Syndrome
191. Low-dose Decitabine Restores Immune Tolerance In Immune Thrombocytopenia Via Modulating Treg Cells And Inhibiting CTLs Toxicity
192. Inhibiting Cardiac Allograft Rejection In Mice By Interleukin-35 Gene Therapy Combined With Decitabine Treatment
193. Study On The Efficacy Of Decitabine For The Treatment Of R/R-AML And MDS And The Mechanism Of DUSP16 In Children With AML
194. Low-dose Decitabine Priming With Intermediate-dose Cytarabine Followed By Umbilical Cord Blood Infusion As Consolidation Therapy For Elderly Patients With Acute Myeloid Leukemia:a Phase Ⅱ Single-arm Study
195. Part Ⅰ Genomic And Transcriptomic Profiling Reveals Distinct Molecular Subsets Associated With Outcome In Mantle Cell Lymphoma Part Ⅱ High Incidence Of MYD88 And KMT2D Mutations In Chinese With Chronic Lymphocytic Leukemia
196. Decitabine-Loaded Gold Nanocages For Photothermal Cancer Therapy
197. Mechanism And Proliferation Promoting Effect Of Low-dose Decitabine On HT29 Colon Cancer Cells
198. The Molecular Mechanism Of Transcript Factor TWIST1 Affecting On DAC Resistance In MDS/AML
199. Clinical Efficacy Of Low-dose Decitabine Combined With Cytarabine In The Treatment Of Patients With High-risk MDS
200. Comparison Of The Efficacy And Safety Of Decitabine Alone Or Combined With Low-dose Chemotherapy In The Treatment Of Myelodysplastic Syndrome With Excess Blasts
  <<First  <Prev  Next>  Last>>  Jump to